Roche Diagnostics has been in Singapore for more than 40 years, and has a direct presence in 16 other countries across the Asia Pacific region. With a mission to improve the lives of patients and to make healthcare sustainable by delivering medical value and testing efficiency, we have established our Regional Headquarters and Centre of Excellence in Singapore. This is an important part of a strategy that will allow us to provide better service through our diagnostic capabilities across the healthcare industry.
Singapore is highly regarded for having first-class healthcare infrastructure and exceptional standards of medical practice, with an environment that supports the innovation and commercialisation of diagnostics products and services.
As the leading provider in diagnostics, we contribute a broad range of innovative products and services that support early detection, prevention, diagnosis and treatment of diseases. Our focus and emphasis on novel and meaningful advances in diagnostic technologies remains core to our strategy today. The key areas covered by Roche’s in-vitro diagnostics portfolio are oncology, cardiovascular and metabolic diseases, infectious diseases, blood screening, women’s health and critical care. The testing solutions are designed for users across the healthcare spectrum – from patients and physicians through to research institutions, hospitals and commercial laboratories.